Treatment of tuberculous meningitis;Traitement des tuberculoses cérébro-méningées

Revue Neurologique

Volumn 162, Issue 5, 2006, Pages 581-593

  Steichen, O ^a   Martinez Almoyna, L ^a   De Broucker, T ^a  

^a DELAFONTAINE HOSPITAL   (France)

Author keywords

Antitubercular agents; Glucocorticoids; Tuberculoma; Tuberculous meningitis

Indexed keywords

ACETAZOLAMIDE; AMIKACIN; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIINFLAMMATORY AGENT; CAPREOMYCIN; CARBAMAZEPINE; CLOFAZIMINE; CORTICOSTEROID; CYCLOSERINE; DIAZEPAM; DIURETIC AGENT; ETHAMBUTOL; ETHIONAMIDE; ETHOSUXIMIDE; GLUCOCORTICOID; ISONIAZID; LAMOTRIGINE; MOXIFLOXACIN; PHENOBARBITAL; PHENYTOIN; PREDNISONE; PYRAZINAMIDE; PYRIDOXINE; RIFAMPICIN; SODIUM CHLORIDE; STREPTOMYCIN; TUBERCULOSTATIC AGENT; UNINDEXED DRUG; VALPROIC ACID;

CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC IMAGING; DIURETIC THERAPY; HUMAN; HYDROCEPHALUS; HYPONATREMIA; KIDNEY FAILURE; LIVER DISEASE; LIVER TOXICITY; LUMBAR PUNCTURE; MENINGOENCEPHALITIS; NEUROPATHY; NEUROSURGERY; PROGNOSIS; REVIEW; RISK ASSESSMENT; TREATMENT DURATION; TUBERCULOMA; TUBERCULOUS MENINGITIS; VOMITING; WASTING SYNDROME; WATER DEPRIVATION; ANTIBIOTIC RESISTANCE; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG COMBINATION;

ADRENAL CORTEX HORMONES; ANTITUBERCULAR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; HUMANS; TUBERCULOMA, INTRACRANIAL; TUBERCULOSIS, MENINGEAL;

EID: 33646739527     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(06)75052-4     Document Type: Article

References (114)

1. AFGHANI B, LIEBERMAN JM. (1994). Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis, 19: 1092-1099.
2. AHUJA GK, MOHAN KK, PRASAD K, BEHARI M. (1994). Diagnostic criteria for tuberculous meningitis and their validation. Tuber Lung Dis, 75: 149-152.
3. AIT-KALED N, ENARSON DA. (2003). Tuberculosis. A manual for medical students. World Health Organization. Geneva.
4. ALZEER AH, FITZGERALD JM. (1993). Corticosteroids and tuberculosis: risks and use as adjunct therapy. Tuber Lung Dis, 74: 6-11.
5. ANGLARET X, SABA J, PERRONNE C et al. (1994). Empiric antituberculosis treatment: benefits for earlier diagnosis and treatment of tuberculosis. Tuber Lung Dis, 75: 334-340.
6. ARVANITAKIS Z, LONG RL, HERSHFIELD ES et al. (1998). M. tuberculosis molecular variation in CNS infection: evidence for strain-dependent neurovirulence. Neurology, 50: 1827-1832.
7. ARVIND C, KORATH MP, RAVEENDRANADHAN K, JAGADEESAN K. (1993). A retrospective study of 1247 cases of intracranial tuberculomata diagnosed by computerized tomography. J Assoc Physicians India, 41: 559-561.
8. AWADA A, DAIF AK, PIRANI M, KHAN MY, MEMISH Z, AL RAJEH S. (1998). Evolution of brain tuberculomas under standard antituberculous treatment. J Neurol Sci, 156: 47-52.
9. BAZIN C. (2004). Tuberculose du système nerveux central. Encyclopédie Médico-Chirurgicale 17-054-A-10: 1-15.
10. BERENGUER J, MORENO S, LAGUNA F et al. (1992). Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med, 326: 668-672.
11. BERGER JR. (1994). Tuberculous meningitis. Curr Opin Neurol, 7: 191-200.
12. BETJES MG. (2002). Hyponatremia in acute brain disease: the cerebral salt wasting syndrome. Eur J Intern Med, 13: 9-14.
13. BIDSTRUP C, ANDERSEN PH, SKINHOJ P, ANDERSEN AB. (2002). Tuberculous meningitis in a country with a low incidence of tuberculosis: still a serious disease and a diagnostic challenge. Scand J Infect Dis, 34: 811-814.
14. BLUMBERG HM, BURMAN WJ, CHAISSON RE et al. (2003). American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med, 167: 603-662.
15. BRITISH MEDICAL RESEARCH COUNCIL. (1948). Streptomycin treatment of tuberculous meningitis. Lancet, i: 582-597.
16. BRITISH THORACIC SOCIETY. (1998). Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society. Thorax, 53: 536-548.
17. BULLOCK MR, WELCHMAN JM. (1982). Diagnostic and prognostic features of tuberculous meningitis on CT scanning. J Neurol Neurosurg Psychiatry, 45: 1098-1101.
18. CAILHOL J, CHE D, CAMPESE C, DECLUDT B. (2003). Cas de tuberculose déclarés en France en 2001. Bulletin Épidémiologique Hebdomadaire, 10-11: 54-57.
19. CARLSON HB, ANTHONY EM, RUSSELL WF, MIDDLEBROOK G. (1956). Prophylaxis of isoniazid neuropathy with pyridoxine. N Engl J Med, 255: 118-122.
20. CENTERS FOR DISEASE CONTROL AND PREVENTION. (1998). Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR, 47: 1-58.
21. CHOTMONGKOL V, PANTHAVASIT J, TIAMKAO S, JITPIMOLMARD S. (2003). Tuberculous meningitis in adults: a four-year review during 1997-2000. Southeast Asian J Trop Med Public Health, 34: 869-871.
22. COYLE PK. (1999). Glucocorticoids in central nervous system bacterial infection. Arch Neurol, 56: 796-801.
23. CONSEIL SUPÉRIEUR D'HYGIèNE PUBLIQUE. (2003). Prévention et prise en charge de la tuberculose en France. Synthèse et recommandations du groupe de travail du Conseil Supérieur d'Hygiène Publique en France. Rev Mal Respir, 20: S3-S106.
24. DASTUR DK, MANGHANI DK, UDANI PM. (1995). Pathology and pathogenetic mechanisms in neurotuberculosis. Radiol Clin North Am, 33: 733-752.
25. DAVIS LE, RASTOGI KR, LAMBERT LC, SKIPPER BJ. (1993). Tuberculous meningitis in the southwest United States: a community-based study. Neurology, 43: 1775-1778.
26. DOGANAY M, CALANGU S, TURGUT H, BAKIR M, AYGEN B. (1995). Treatment of tuberculous meningitis in Turkey. Scand J Infect Dis, 27: 135-138.
27. DONALD PR, SCHAAF HS, SCHOEMAN JF. (2005). Tuberculous meningitis and miliary tuberculosis: the Rich focus revisited. J Infect, 50: 193-195.
28. DONALD PR, SCHOEMAN JF. (2004). Tuberculous meningitis. N Engl J Med, 351: 1719-1720.
29. DOOLEY DP, CARPENTER JL, RADEMACHER S. (1997). Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis, 25: 872-887.
30. DUBÉ MP, HOLTOM PD, LARSEN RA. (1992). Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med, 93: 520-524.
31. FARINHA NJ, RAZALI KA, HOLZEL H, MORGAN G, NOVELLI VM. (2000). Tuberculosis of the central nervous system in children: a 20-year survey. J Infect, 41: 61-68.
32. GARCIA-MONCO JC. (1999). Central nervous system tuberculosis. Neurol Clin, 17: 737-759.
33. GARG RK. (1999). Tuberculosis of the central nervous system. Postgrad Med J, 75: 133-140.
34. GELBAND H. (2000). Regimens of less than six months for treating tuberculosis. Cochrane Database Syst Rev: CD001362.
35. GIRGIS NI, FARID Z, KILPATRICK ME, SULTAN Y, MIKHAIL IA. (1991). Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J, 10: 179-183.
36. GIRGIS NI, SULTAN Y, FARID Z et al. (1998). Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996. Am J Trop Med Hyg, 58: 28-34.
37. GOEL A, PANDYA SK, SATOSKAR AR. (1990). Whither short-course chemotherapy for tuberculous meningitis? Neurosurgery, 27: 418-421.
38. GROSSET J. (1995). Place des examens microbiologiques et anatomopathologiques dans la décision diagnostique et thérapeutique. Med Mal Infect, 25 : 327-333.
39. GUPTA RK, KOHLI A, GAUR V, LAL JH, KISHORE J. (1997). MRI of the brain in patients with miliary pulmonary tuberculosis without symptoms or signs of central nervous system involvement. Neuroradiology, 39: 699-704.
40. HOLDINESS MR. (1987). Neurological manifestations and toxicities of the antituberculosis drugs. A review. Med Toxicol, 2: 33-51.
41. HOLDINESS MR. (1990). Management of tuberculosis meningitis. Drugs, 39: 224-233.
42. HOSOGLU S, GEYIK MF, BALIK I et al. (2002). Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis, 6: 64-70.
43. HSIEH FY, CHIA LG, SHEN WC. (1992). Locations of cerebral infarctions in tuberculous meningitis. Neuroradiology, 34: 197-199.
44. HUMPHRIES M. (1992). The management of tuberculous meningitis. Thorax, 47: 577-581.
45. HUMPHRIES MJ, TEOH R, LAU J, GABRIEL M. (1990). Factors of prognostic significance in Chinese children with tuberculous meningitis. Tubercle, 71: 161-168.
46. JARLIER V, CAMBAU E, SOUGAKOFF W. (2004). Quels sont les nouveaux outils diagnostiques de la tuberculose ? Quel est leur intérêt pour la prise en charge du malade et quelles sont leurs indications ? Les tests d'amplification génique. Rev Mal Respir, 21: S36-S43.
47. JINKINS JR. (1991). Computed tomography of intracranial tuberculosis. Neuroradiology, 33: 126-135.
48. JINKINS JR, GUPTA R, CHANG KH, RODRIGUEZ-CARBAJAL J. (1995). MR imaging of central nervous system tuberculosis. Radiol Clin North Am, 33: 771-786.
49. JOOSTEN AA, VAN DER VALK PD, GEELEN JA, SEVERIN WP, JANSEN STEUR EN. (2000). Tuberculous meningitis: pitfalls in diagnosis. Acta Neurol Scand, 102: 388-394.
50. JOURNAL OFFICIEL. (1993). Décret 93-1021 du 26/08/1993 relatif aux modalités de constatation des soins prescrits aux assurés sociaux atteints d'une affection de longue durée et modifiant le code de Sécurité Sociale.
51. JOURNAL OFFICIEL. (1999). Décret 99-363 du 06/05/1999 fixant la liste des maladies faisant l'objet d'une transmission obligatoire de données individuelles à l'autorité sanitaire et modifiant le Code de la Santé Publique.
52. KAOJARERN S, SUPMONCHAI K, PHUAPRADIT P, MOKKHAVESA C, KRITTIYANUNT S. (1991). Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis. Clin Pharmacol Ther, 49: 6-12.
53. KARSTAEDT AS, VALTCHANOVA S, BARRIERE R, CREWE-BROWN HH. (1998). Tuberculous meningitis in South African urban adults. QJM, 91: 743-747.
54. KATRAK SM, SHEMBALKAR PK, BIJWE SR, BHANDARKAR LD. (2000). The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci, 181: 118-126.
55. KATTI MK. (2004). Pathogenesis, diagnosis, treatment, and outcome aspects of cerebral tuberculosis. Med Sci Monit, 10: RA215-29.
56. KENT SJ, CROWE SM, YUNG A, LUCAS CR, MIJCH AM. (1993). Tuberculous meningitis: a 30-year review. Clin Infect Dis, 77: 987-994.
57. KILANI B, AMMARI L, TIOUIRI H et al. (2003). Manifestations neuroradiologiques initiales de la tuberculose du systeme nerveux central de l'adulte. À propos de 122 cas. Rev Med Interne, 24 : 86-96.
58. KINGSLEY DP, HENDRICKSE WA, KENDALL BE, SWASH M, SINGH V. (1987). Tuberculous meningitis: role of CT in management and prognosis. J Neurol Neurosurg Psychiatry, 50: 30-36.
59. KUMAR R, SINGH SN, KOHLI N. (1999). A diagnostic rule for tuberculous meningitis. Arch Dis Child, 81: 221-224.
60. LAM KS, SHAM MM, TAM SC, NG MM, MA HAT. (1993). Hypopituitarism after tuberculous meningitis in childhood. Ann Intern Med, 118: 701-706.
61. LEJEUNE B, MOCQUARD Y, ESTIENNE E et al. (1987). Tuberculomes intra cérébraux : À propos de deux observations. Méd Mal Infect, 17: 38-40.
62. LEONARD JM, DES PREZ RM. (1990). Tuberculous meningitis. Infect Dis Clin North Am, 4: 769-787.
63. LINCOLN EM. (1947). Tuberculous meningitis in children. Am Rev Tuberc, 56: 75-109.
64. LU CH, CHANG WN, CHANG HW. (2001). The prognostic factors of adult tuberculous meningitis. Infection, 29: 299-304.
65. MANABE YC, CHAISSON RE. (2002). Tuberculosis. In: Asbury AK, McKhann GM, McDonald WI, Goadsby PJ, McArthur JC. Diseases of the nervous system. Clinical neuroscience and therapeutic principles. 3 ed. Cambridge University Press. Cambridge. Vol. 2, pp. 1777-1790.
66. MARSHALL BG, CHAMBERS MA. (1998). Central nervous system tuberculosis - the paradox of the host immune response. J Infect, 36: 3-4.
67. MATHEW JM, RAJSHEKHAR V, CHANDY MJ. (1998). Shunt surgery in poor grade patients with tuberculous meningitis and hydrocephalus: effects of response to external ventricular drainage and other variables on long term outcome. J Neurol Neurosurg Psychiatry, 65: 115-118.
68. MCCUNE R, DEUSCHLE K, MCDERMOTT W. (1957). The delayed appearence of isoniazid antagonism by pyridoxin in vivo. Am Tuberc Pulm Dis, 76: 1100-1105.
69. MIGLIORI GB, RAVIGLIONE MC, SCHABERG T et al. (1999). Tuberculosis management in Europe. Task Force of the European Respiratory Society (ERS), the World Health Organisation (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) Europe Region. Eur Respir J, 14: 978-992.
70. MISRA UK, KALITA J, ROY AK, MANDAL SK, SRIVASTAVA M. (2000). Role of clinical, radiological, and neurophysiological changes in predicting the outcome of tuberculous meningitis: a multivariable analysis. J Neurol Neurosurg Psychiatry, 68: 300-303.
71. MISRA UK, KALITA J, SRIVASTAVA M, MANDAL SK. (1996). Prognosis of tuberculous meningitis: a multivariate analysis. J Neurol Sci, 137: 57-61.
72. MIZUTANI T, KUROSAWA N, MATSUNO Y, MIYAGAWA M, MATSUYA S, AIBA T. (1993). Atypical manifestations of tuberculous meningitis. Eur Neurol, 33: 159-162.
73. MOHANTY A, VENKATARAMA SK, VASUDEV MK, KHANNA N, ANANDH B. (1999). Role of stereotactic aspiration in the management of tuberculous brain abscess. Surg Neurol, 51: 443-446 ; [discussion 446-447].
74. MOLAVI A, LEFROCK JL. (1985). Tuberculous meningitis. Med Clin North Am, 69: 315-331.
75. OFFENBACHER H, FAZEKAS F, SCHMIDT R et al. (1991). MRI in tuberculous meningoencephalitis: report of four cases and review of the neuroimaging literature. J Neurol, 238: 340-344.
76. OGAWA SK, SMITH MA, BRENNESSEL DJ, LOWY FD. (1987). Tuberculous meningitis in an urban medical center. Medicine (Baltimore), 66: 317-326.
77. OMS-UICTMR. (2003). Treatment of tuberculosis: Guidelines for national programmes. 3 ed. World Health Organization. Geneva.
78. PAI M, FLORES LL, PAI N, HUBBARD A, RILEY LW, COLFORD JM. (2003). Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis, 3: 633-643.
79. PALUR R, RAJSHEKHAR V, CHANDY MJ, JOSEPH T, ABRAHAM J. (1991). Shunt surgery for hydrocephalus in tuberculous meningitis: a long-term follow-up study. J Neurosurg, 74: 64-69.
80. PARSONS M. (1989). The treatment of tuberculous meningitis. Tubercle, 70: 79-82.
81. PORKERT MT, SOTIR M, PARROTT-MOORE P, BLUMBERG HM. (1997). Tuberculous meningitis at a large inner-city medical center. Am J Med Sci, 313: 325-331.
82. PRASAD K, VOLMINK J, MENON GR. (2000). Steroids for treating tuberculous meningitis. Cochrane Database Syst Rev, 3: CD002244.
83. RAJESWARI R, SIVASUBRAMANIAN S, BALAMBAL R et al. (1995). A controlled clinical trial of short-course chemotherapy for tuberculoma of the brain. Tuber Lung Dis, 76: 311-317.
84. RAMACHANDRAN P, DURAIPANDIAN M, REETHA AM, MAHALAKSHMI SM, PRABHAKAR R. (1989). Long-term status of children treated for tuberculous meningitis in south India. Tubercle, 70: 235-239.
85. RIEDER HL. (2002). Interventions for tuberculosis control and elimination, international union against tuberculosis and lung disease. Paris.
86. nd Ed. Academic Press. San Diego.
87. SCHOEMAN J, DONALD P, VAN ZYL L, KEET M, WAIT J. (1991). Tuberculous hydrocephalus: comparison of different treatments with regard to ICP, ventricular size and clinical outcome. Dev Med Child Neurol, 33: 396-405.
88. SCHOEMAN J, HEWLETT R, DONALD P. (1988). MR of childhood tuberculous meningitis. Neuroradiology, 30: 473-477.
89. SCHOEMAN J, WAIT J, BURGER M et al. (2002). Long-term follow up of childhood tuberculous meningitis. Dev Med Child Neurol, 44: 522-526.
90. SCHOEMAN JF, VAN ZYL LE, LAUBSCHER JA, DONALD PR. (1995). Serial CT scanning in childhood tuberculous meningitis: prognostic features in 198 cases. J Child Neurol, 10: 320-329.
91. SISKIND MS, THIENEMANN D, KIRLIN L. (1993). Isoniazid-induced neurotoxicity in chronic dialysis patients: report of three cases and a review of the literature. Nephron, 64: 303-306.
92. SMITH H. (1987). Paradoxical responses during the chemotherapy of tuberculosis. J Infect, 15: 1-3.
93. SNIDER DE. (1980). Pyridoxine supplementation during isoniazid therapy. Tubercle, 61: 191-196.
94. SOCIÉTÉ DE PNEUMOLOGIE DE LANGUE FRANÇAISE. (2004). Recommandations de la société de pneumologie de langue française sur la prise en charge de la tuberculose en France: conférence d'experts. Rev Mal Respir, 21: S3-S104.
95. STARKE JR. (1999). Tuberculosis of the central nervous system in children. Semin Pediatr Neurol, 6: 318-31.
96. SUTLAS PN, UNAL A, FORTA H, SENOL S, KIRBAS D. (2003). Tuberculous meningitis in adults: review of 61 cases. Infection, 31: 387-391.
97. TANDON PN, BHARGAVA S. (1985). Effect of medical treatment on intracranial tuberculoma - a CT study. Tubercle, 66: 85-97.
98. TEOH R, O'MAHONY G, YEUNG VT. (1986). Polymorphonuclear pleocytosis in the cerebrospinal fluid during chemotherapy for tuberculous meningitis. J Neurol, 233: 237-241.
99. THWAITES GE, CHAU TT, FARRAR JJ. (2004). Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol, 42: 378-379.
100. THWAITES GE, CHAU TT, MAI NT, DROBNIEWSKI F, MCADAM K, FARRAR J. (2000). Tuberculous meningitis. J Neurol Neurosurg Psychiatry, 68: 289-299.
101. THWAITES GE, CHAU TT, STEPNIEWSKA K et al. (2002). Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet, 360: 1287-1292.
102. THWAITES GE, NGUYEN DB, NGUYEN HD et al. (2004). Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med, 351: 1741-1751.
103. THWAITES GE, LAN NT, DUNG NH et al. (2005). Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis, 192: 79-88.
104. THWAITES GE, TRAN TH. (2005). Tuberculous meningitis: many questions, too few answers. Lancet Neurol, 4: 160-170.
105. nd ed. World Health Organization. Geneva.
106. TRAUB M, COLCHESTER AC, KINGSLEY DP, SWASH M. (1984). Tuberculosis of the central nervous system. Q J Med, 53: 81-100.
107. UDANI PM, DASTUR DK. (1970). Tuberculous encephalopathy with and without meningitis. Clinical features and pathological correlations. J Neurol Sci, 10: 541-561.
108. UDANI PM, PAREKH UC, DASTUR DK. (1971). Neurological and related syndromes in CNS tuberculosis. Clinical features and pathogenesis. J Neurol Sci, 14: 341-357.
109. VAN LOENHOUT-ROOYACKERS JH, KEYSER A, LAHEIJ RJ, VERBEEK AL, VAN DER MEER JW. (2001). Tuberculous meningitis: is a 6-month treatment regimen sufficient? Int J Tuberc Lung Dis, 5: 1028-1035.
110. VERDON R, CHEVRET S, LAISSY JP, WOLFF M. (1996). Tuberculous meningitis in adults: review of 48 cases. Clin Infect Dis, 22: 982-988.
111. VIDAL JE, OLIVEIRA AC, FILHO FB et al. (2005). Tuberculous brain abscess in AIDS patients: report of three cases and literature review. Int J Infect Dis, 9: 201-207.
112. VILLORIA MF, FORTEA F, MORENO S, MUNOZ L, MANERO M, BENITO C. (1995). MR imaging and CT of central nervous system tuberculosis in the patient with AIDS. Radiol Clin North Am, 33: 805-820.
113. th ed. Oxford University Press. Oxford. Vol. 3, pp. 1124-1129.
114. YECHOOR VK, SHANDERA WX, RODRIGUEZ P, CATE TR. (1996). Tuberculous meningitis among adults with and without HIV infection. Experience in an urban public hospital. Arch Intern Med, 156: 1710-1716.